Claudia Filozof, MD, PhD, Vice President, Liver Theraputic Area

• Board-certified in nutrition in metabolism
• 20+ years of experience in clinical research in the pharma and CRO businesses
• Leads development programs on obesity and diabetes and has been fully dedicated to NAFLD/NASH and cholestatic liver diseases since 2011
• Member of the Liver and PSC Forum, AASLD steatohepatitis working group and EASL NAFLD group
• Author of multiple manuscripts including six recent review papers about clinical development in NASH and adaptive design studies